• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Transforming Oncology Care With AI-Driven Insights

News
Video

Leveraging Microsoft’s Azure OpenAI, Ontada streamlines oncology data analysis, reducing processing times by 85% to support clinical decisions and improve patient care for over 3000 oncologists across 30 states, according to Wanmei Ou, PhD, vice president of product, data analytics, and artificial intelligence (AI) at Ontada.

Ontada, a McKesson business unit, has revolutionized oncology data management with its flagship electronic health record (EHR) system, iKnowMed, used by more than 3000 community-based oncologists and supporting millions of patients. Rigorous model development and ongoing monitoring ensure data quality, while future innovations focus on expanding real-world data applications in oncology research and addressing health equity in rural communities.

Wanmei Ou, PhD, vice president of product, data analytics, and artificial intelligence (AI) at Ontada, discusses how by partnering with Microsoft, Ontada has reduced oncology data processing from 6 months to just weeks, alleviating documentation burdens and enhancing clinical decision support.

Ou explained the importance of using AI and natural language processing (NLP) to unlock unstructured data in oncology, as 70% to 80% of critical patient information is embedded in nonstandardized documents due to the interdisciplinary nature of oncology care. These data span across diverse systems and involve various specialists, including oncologists, surgeons, and primary care providers.

AI applications in this field serve 3 primary use cases, according to Ou. The first use is extracting real-world evidence from unstructured data for organized access. Second, AI applications reduce documentation burdens, allowing physicians to focus more on patient care than data entry. Third, these applications provide clinical decision support by integrating patient context, treatment guidelines, and insurance policies to recommend optimal next steps.

Ontada processes a massive amount of unstructured data—around 150 million documents from 2 to 3 million patients’ longitudinal records, said Ou. Due to the sheer scale, even Microsoft hadn’t previously encountered such a high-volume processing need within a short time frame. Through close collaboration and multiple on-site meetings with Microsoft’s technical specialists, Ontada leveraged the new Azure OpenAI, reducing processing time from an expected 6 months to just 2 to 3 weeks. This partnership has enabled Ontada to handle vast data more efficiently, and the solution may benefit other organizations facing similar high-volume data challenges, Ou noted.

Related Videos
Jawad Haider Butt, MD, PhD
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Andrew Kuykendall, MD, Moffitt Cancer Center
Anna Mueller, MD, Mount Sinai
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.